Mitochondria-Rich Fraction Isolated From Mesenchymal Stromal Cells Reduces Lung and Distal Organ Injury in Experimental Sepsis

• Published in: Critical care medicine Vol. 49; no. 9; p. e880
• Main Authors: de Carvalho, Luiza Rachel Pinheiro, Abreu, Soraia Carvalho, de Castro, Ligia Lins, Andrade da Silva, Luísa Helena, Silva, Paula Matos, Vieira, Juliana Borges, Santos, Renata Trabach, Cabral, Marianna Ribeiro, Khoury, Maroun, Weiss, Daniel J, Lopes-Pacheco, Miquéias, Silva, Pedro Leme, Cruz, Fernanda Ferreira, Rocco, Patricia Rieken Macedo
• Format: Journal Article
• Language: English
• Published: United States 01.09.2021
• Subjects: Animals; Disease Models, Animal; Liver - metabolism; Liver - pathology; Lung - metabolism; Lung - pathology; Mesenchymal Stem Cells - metabolism; Mesenchymal Stem Cells - pathology; Mice; Mice, Inbred C57BL - metabolism; Mitochondria - metabolism; Multiple Organ Failure; Sepsis - complications
• ISSN: 1530-0293
• DOI: 10.1097/CCM.0000000000005056

To ascertain whether systemic administration of mitochondria-rich fraction isolated from mesenchymal stromal cells would reduce lung, kidney, and liver injury in experimental sepsis. Animal study. Laboratory investigation. Sixty C57BL/6 male mice. Sepsis was induced by cecal ligation and puncture; sham-operated animals were used as control. At 24 hours after surgery, cecal ligation and puncture and Sham animals were further randomized to receive saline or mitochondria-rich fraction isolated from mesenchymal stromal cells (3 × 106) IV. At 48 hours, survival, peritoneal bacterial load, lung, kidney, and liver injury were analyzed. Furthermore, the effects of mitochondria on oxygen consumption rate and reactive oxygen species production of lung epithelial and endothelial cells were evaluated in vitro. In vitro exposure of lung epithelial and endothelial cells from cecal ligation and puncture animals to mitochondria-rich fraction isolated from mesenchymal stromal cells restored oxygen consumption rate and reduced total reactive oxygen species production. Infusion of exogenous mitochondria-rich fraction from mesenchymal stromal cells (mitotherapy) reduced peritoneal bacterial load, improved lung mechanics and histology, and decreased the expression of interleukin-1β, keratinocyte chemoattractant, indoleamine 2,3-dioxygenase-2, and programmed cell death protein 1 in lung tissue, while increasing keratinocyte growth factor expression and survival rate in cecal ligation and puncture-induced sepsis. Mitotherapy also reduced kidney and liver injury, plasma creatinine levels, and messenger RNA expressions of interleukin-18 in kidney, interleukin-6, indoleamine 2,3-dioxygenase-2, and programmed cell death protein 1 in liver, while increasing nuclear factor erythroid 2-related factor-2 and superoxide dismutase-2 in kidney and interleukin-10 in liver. Mitotherapy decreased lung, liver, and kidney injury and increased survival rate in cecal ligation and puncture-induced sepsis.